Jeffrey D. Lorenger, President and CEO of HNI Corp (NYSE: HNI), filed a Form 4 on August 5, 2026, disclosing a series of transactions in HNI common stock dated March 17, 2026 and August 3, 2026, including a trust contribution, a stock option exercise, and open-market sales under a Rule 10b5-1 plan.

Key Highlights

  • Trust contribution: On March 17, 2026, Lorenger contributed 96,007 shares of common stock to a revocable trust for the benefit of himself, his spouse, and his children, at $0 per share (disposition coded G).
  • Option exercise: On August 3, 2026, Lorenger exercised 45,850 non-qualifying employee stock options at an exercise price of $46.62 per share (expiration date February 15, 2027), acquiring 45,850 shares of common stock.
  • 10b5-1 plan sales: Also on August 3, 2026, Lorenger sold 35,232 shares at a weighted average price of $47.48 (range $46.650-$47.645) and 10,618 shares at a weighted average price of $47.78 (range $47.65-$48.11), both under a Rule 10b5-1 plan adopted February 27, 2026.
  • Direct ownership following transactions: Lorenger directly held 148,490 shares of common stock after the reported transactions.
  • Indirect holdings: Lorenger also held 313,061.462 shares indirectly through a trust and 7,674.193 shares indirectly through a Profit Sharing Retirement Plan, according to the filing.

HNI Corp CEO Lorenger's August 2026 Transaction Details

According to the filing, the Form 4 covers transactions by Jeffrey D. Lorenger, who is identified as both a Director and President and CEO of HNI Corp. The earliest transaction reported is dated March 17, 2026, when Lorenger transferred 96,007 shares of common stock to a revocable trust. The filing's footnote states this "represents the contribution of these shares to a revocable trust for the benefit of the reporting person, and the reporting person's spouse and children." The transfer was recorded at $0 and coded as a gift (G), reducing his direct holdings to 148,490 shares at that point.

On August 3, 2026, Lorenger exercised 45,850 non-qualifying employee stock options at a conversion price of $46.62 per share. The filing indicates the options had been exercisable since February 15, 2021, with an expiration date of February 15, 2027, and that following the exercise, zero such options remained. The exercise brought his direct share count to 194,340 shares. Also on August 3, 2026, Lorenger sold 35,232 shares and then 10,618 shares in separate transactions, returning his direct holdings to 148,490 shares. The filing notes both sales were made pursuant to a Rule 10b5-1 plan adopted on February 27, 2026. The weighted average prices reported were $47.48 and $47.78, respectively, with both transactions executed across multiple price points within the stated ranges.

The filing was signed by Steven M. Bradford by Power of Attorney on August 5, 2026. The filing notes that Lorenger undertakes to provide full information on shares sold at each separate price within the reported ranges upon request by HNI Corporation, any security holder, or SEC staff.

What Was Disclosed

The filing reported a trust contribution of 96,007 shares, the exercise of 45,850 stock options at $46.62, and the sale of 45,850 total shares under a Rule 10b5-1 plan, with Lorenger directly holding 148,490 shares following all transactions.